The multifunctional APE1 DNA repair–redox signaling protein as a drug target in human disease is a research paper published in Drug Discovery Today (2020). On theSindex it has a DataRank of 0.725. It has been cited 125 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.725
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: R01NF180045
National Cancer Institute
Grant: R01CA205166
U.S. Department of Defense
Grant: W81XWH1910217
National Cancer Institute
Grant: R01CA231267
National Cancer Institute
Grant: R01EY031939
National Cancer Institute
Grant: U01HL143403
National Cancer Institute
Grant: R01CA167291
NCI NIH HHS
Grant: R01 CA211098
NCI NIH HHS
Grant: P30 CA082709
NHLBI NIH HHS
Grant: R01 HL140961
National Institutes of Health
Riley Children's Foundation
FWCI
4.38
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals